PPARG and type 2 diabetes mellitus: PPARγ was activated by the thiazolidinediones (TZDs), a group of drugs widely used in patients in the management of type 2 diabetes (T2D), as they regulate glucose metabolism, adiposeness, differentiation, and the expression of several genes including antioxidant defenses14, 20.